The Emerging Importance of Tumor Genomics in Operable Non-Small Cell Lung Cancer
During the last two decades, next-generation sequencing (NGS) has played a key role in enhancing non-small cell lung cancer treatment paradigms through the application of “targeted therapy” in advanced and metastatic disease. The use of specific tyrosine kinase inhibitors in patients with oncogenic...
Main Authors: | Harry B. Lengel, James G. Connolly, Gregory D. Jones, Raul Caso, Jian Zhou, Francisco Sanchez-Vega, Brooke Mastrogiacomo, James M. Isbell, Bob T. Li, Yuan Liu, Natasha Rekhtman, David R. Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3656 |
Similar Items
-
Next Generation Sequencing Technology in Lung Cancer Diagnosis
by: Calin Cainap, et al.
Published: (2021-09-01) -
Impact of donor lung colonized bacteria detected by next-generation sequencing on early post-transplant outcomes in lung transplant recipients
by: Dong Liu, et al.
Published: (2020-09-01) -
Important Role of Deduplication Method in Next Generation Sequencing Data Analysis of Non-small Cell Lung Cancer
by: CHEN Yu, et al.
Published: (2018-01-01) -
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
by: Roberto Ruiz-Cordero, et al.
Published: (2020-01-01) -
Personalized Targeted Therapy for Lung Cancer
by: William C.S. Cho, et al.
Published: (2012-09-01)